Dublin, Dec. 18, 2018 (GLOBE NEWSWIRE) -- The "Global Blood Glucose Test Strips Market - Forecasts From 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.

The blood glucose test strips is projected to grow at a CAGR of 5.65% to reach US$14.191 billion by 2023, from US$10.204 billion in 2017.

Growing prevalence if diabetes around the globe is considered as the key driver for the growth of the blood glucose test strips market as diabetes treatment requires consistent monitoring of the blood glucose levels. According to World Health Organization number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.

Moreover increasing healthcare expenditure is also considered as the key driver for the growth of the market.

APAC is expected to be the fastest growing region for blood glucose test strips market due to rise in the prevalence of diabetes and increasing awareness about the USAge of various devices to test diabetes.

Major industry players profiled as part of the report are Medtronic, Johnson & Johnson, AgaMatrix, Inc., Abbott Diabetes Care, Arkray and Roche among others.

Key Topics Covered

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. BLOOD GLUCOSE TEST STRIPS BY DIABETES TYPE
5.1. Type I Diabetes
5.2. Type II Diabetes

6. BLOOD GLUCOSE TEST STRIPS BY DISTRIBUTION CHANNEL
6.1. Online
6.2. Offline

7. BLOOD GLUCOSE TEST STRIPS BY END-USER
7.1. Hospitals and Clinics
7.2. Ambulatory Surgery Centers
7.3. Diagnostic Centers

8. BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific

9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES
10.1. Medtronic
10.2. Johnson & Johnson
10.3. AgaMatrix, Inc.
10.4. Abbott Diabetes Care
10.5. Arkray
10.6. Roche
10.7. LifeScan
10.8. Ypsomed Holding AG
10.9. Sanofi
10.10. Dexcom

For more information about this report visit https://www.researchandmarkets.com/research/wnfcth/blood_glucose?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Glucose Testing, Diabetes Devices 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.